Issue 44, 2025

A self-assembled fusion hydrophobin-coated nanodiamond system for synergistic targeted therapy of colorectal cancer

Abstract

A novel nano-platform (GE11-HGFI@ND-DOX) capable of specifically targeting colorectal cancer HCT-116 cells with highly expressed EGFR receptors, exhibiting precise targeting and enhanced therapy, while enhancing its dispersivity and hydrophilicity is reported. This work opens up prospects for the development of synergistic targeted therapy by integrating hydrophobins and nanodiamond encapsulated drug delivery systems.

Graphical abstract: A self-assembled fusion hydrophobin-coated nanodiamond system for synergistic targeted therapy of colorectal cancer

Supplementary files

Article information

Article type
Communication
Submitted
20 Feb 2025
Accepted
16 Apr 2025
First published
26 Apr 2025

Chem. Commun., 2025,61, 8075-8078

A self-assembled fusion hydrophobin-coated nanodiamond system for synergistic targeted therapy of colorectal cancer

H. Li, Y. Wang, H. Qiao, F. Liu, Z. Li, Z. Han, Z. Guo, Y. Li and M. Qiao, Chem. Commun., 2025, 61, 8075 DOI: 10.1039/D5CC00919G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements